MTLC Stock Overview
Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
MTL Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.18 |
| 52 Week High | CA$0.69 |
| 52 Week Low | CA$0.10 |
| Beta | 0 |
| 11 Month Change | 15.63% |
| 3 Month Change | 5.71% |
| 1 Year Change | -61.46% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.00% |
Recent News & Updates
Is MTL Cannabis (CSE:MTLC) Using Too Much Debt?
Oct 31
Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 26% Bounce
Aug 11The Strong Earnings Posted By MTL Cannabis (CSE:MTLC) Are A Good Indication Of The Strength Of The Business
Aug 05Shareholder Returns
| MTLC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 15.6% | -6.1% | 0.7% |
| 1Y | -61.5% | -22.3% | 21.7% |
Return vs Industry: MTLC underperformed the Canadian Pharmaceuticals industry which returned -22.8% over the past year.
Return vs Market: MTLC underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| MTLC volatility | |
|---|---|
| MTLC Average Weekly Movement | 18.8% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: MTLC's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: MTLC's weekly volatility has decreased from 29% to 19% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Mike Perron | www.mtlcannabis.ca |
MTL Cannabis Corp., through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. The company offers dried flower, pre-rolls, and hash products. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions.
MTL Cannabis Corp. Fundamentals Summary
| MTLC fundamental statistics | |
|---|---|
| Market cap | CA$20.47m |
| Earnings (TTM) | CA$4.84m |
| Revenue (TTM) | CA$73.25m |
4.5x
P/E Ratio0.3x
P/S RatioIs MTLC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MTLC income statement (TTM) | |
|---|---|
| Revenue | CA$73.25m |
| Cost of Revenue | CA$32.60m |
| Gross Profit | CA$40.65m |
| Other Expenses | CA$35.81m |
| Earnings | CA$4.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.041 |
| Gross Margin | 55.50% |
| Net Profit Margin | 6.61% |
| Debt/Equity Ratio | 127.4% |
How did MTLC perform over the long term?
See historical performance and comparison